A Sodium, Croscarmellose CEP of the European Pharmacopoeia monograph is often referred to as a Sodium, Croscarmellose Certificate of Suitability (COS). The purpose of a Sodium, Croscarmellose CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Sodium, Croscarmellose EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Sodium, Croscarmellose to their clients by showing that a Sodium, Croscarmellose CEP has been issued for it. The manufacturer submits a Sodium, Croscarmellose CEP (COS) as part of the market authorization procedure, and it takes on the role of a Sodium, Croscarmellose CEP holder for the record. Additionally, the data presented in the Sodium, Croscarmellose CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Sodium, Croscarmellose DMF.
A Sodium, Croscarmellose CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Sodium, Croscarmellose CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Sodium, Croscarmellose suppliers with CEP (COS) on PharmaCompass.